@FierceBiotech: Adding iridium may offer a new approach to antibiotic resistance. FierceBiotechResearch story | Follow @FierceBiotech
@JohnCFierce: Building its cardio drug portfolio, Amgen bags Dezima in $1.55B deal. News | Follow @JohnCFierce
@DamianFierce: "Ubiquitin" sounds like a McGuffin from a bad sci-fi movie and also it's the target of a new $150M $CELG partnership. Release | Follow @DamianFierce
> Roche ($RHHBY) CEO Severin Schwann reiterated his concerns that biotech is in the midst of a "bubble," saying valuations of small drugmakers have become prohibitively high. News
> AbbVie ($ABBV) and partner Neurocrine Biosciences ($NBIX) are planning to launch a Phase III trial of their uterine fibroid treatment elagolix in early 2016 after tracking a positive effect in Phase IIb. More
> Amid rampant M&A in biopharma, diabetes magnate Novo Nordisk ($NVO) has largely shied away from big deals, part of CEO Lars Sørensen's ethos of focusing on organic growth. Story
Medical Device News
@FierceMedDev: MDxHealth's $8.8M acquisition of NovioGendix is a liquid biopsy play. FierceDiagnostics article | Follow @FierceMedDev
@VarunSaxena2: UPDATED: FDA begs manufacturers to participate in global single audit pilot, says next stage may not be voluntary. ICYMI | Follow @VarunSaxena2
@EmilyWFierce: Germany's ERBA Diagnostics grabs Lumora for molecular Dx tech. FierceDiagnostics story | Follow @EmilyWFierce
> Pentax backs $8M+ round for electrosurgery startup Creo. More
> Illumina, Sloan Kettering partner to develop circulating tumor DNA diagnostics. Article
Pharma News
@FiercePharma: Report: Cancer drug spending fuels large increases in Medicare discount drug program. More | Follow @FiercePharma
@CarlyHFierce: ICYMI: Boehringer's Ofev, chasing a Roche rival, wins backing from NICE. More | Follow @CarlyHFierce
> Will payers make SGLT2 moves on Jardiance CV data? Not just yet. More
> Analysis: New Novartis heart failure med has consumers talking. Item
> Report: Cancer drug spending fuels large increases in Medicare discount drug program. Article
Biotech Research News
> Controversial resveratrol triggers new headlines--this time for Alzheimer's. Story
> Stanford team spotlights a new target for childhood brain tumors. Report
> Adding iridium may offer a new approach to antibiotic resistance. Story
> Caltech IDs an antibody that can thwart HIV. Item
> U.K. investigators say diabetes drug may target pancreatic cancer stem cells. Article
Diagnostics News
> Agilent buys Seahorse Bio for $235M to increase presence in research labs. More
> MDxHealth's $8.8M acquisition of NovioGendix is a liquid biopsy play. News
> Exosome Diagnostics reveals positive data for lung cancer liquid biopsy test. Story
> Foundation Medicine unveils new NGS cancer tool amid sluggish reimbursement. Article
> Pathway Genomics launches liquid biopsy test for early cancer screening. Report
Pharma Marketing News
> GSK settles big media review, chooses incumbents for estimated $900M account. Report
> Gallup charts another big slide for pharma's public image. Story
> Faster track to 'megablockbuster'? Novartis' Entresto already soaring on social media. Article
> Obama taps former Duke researcher to lead FDA. Item
> How much is first-to-market worth? There's a formula for that. More